News
Video
Podcasts
Journals
Conferences
Events
Resources
CE
About AJMC
Subscribe

Spotlight -

Free In-Person Regional Events Focused on Oncology and Population Health

Thomas E. Delea, MSIA

Articles by Thomas E. Delea, MSIA

Cost-effectiveness of Extended Adjuvant Letrozole Therapy After 5 Years of Adjuvant Tamoxifen Therapy in Postmenopausal Women With Early-stage Breast Cancer

ByThomas E. Delea, MSIA,Jonathan Karnon, MSc, PhD,Robert E. Smith, MD,Stephen R. D. Johnston, MD, PhD, FRCP,Jane Brandman, BPharm, MS,Jennifer C. Y. Sung, PharmD,Paul E. Goss, MD, PhD, FRCPC, FRCP(UK)

July 15th 2006

Latest Updated Articles

Cost-effectiveness of Extended Adjuvant Letrozole Therapy After 5 Years of Adjuvant Tamoxifen Therapy in Postmenopausal Women With Early-stage Breast Cancer
Published: July 15th 2006 | Updated:

Trending on AJMC

Newly Unveiled ACA Premiums Show 26% Average Increase Before Subsidy Expiration

FDA Guidance to Remove One of the Largest Barriers to Biosimilar Development

Measles Outbreaks Cause Financial, Public Health Burden in US

New PBM Laws Seek to Protect Independent Pharmacies but Could Raise Costs, Limit Patient Access

Boosting RSV Vaccination in Older Adults Could Save Thousands

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

© 2025 MJH Life Sciences^®

All rights reserved.